427 related articles for article (PubMed ID: 25820608)
1. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
[TBL] [Abstract][Full Text] [Related]
2. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
[TBL] [Abstract][Full Text] [Related]
3. Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
Iehara T; Yoneda A; Yokota I; Takahashi H; Teramukai S; Kamijyo T; Nakazawa A; Takimoto T; Kikuta A; Yagyu S; Ikeda H; Nakagawara A; Tajiri T;
Pediatr Blood Cancer; 2019 Nov; 66(11):e27914. PubMed ID: 31342649
[TBL] [Abstract][Full Text] [Related]
4. Image-defined risk factors in unresectable neuroblastoma: SIOPEN study on incidence, chemotherapy-induced variation, and impact on surgical outcomes.
Avanzini S; Pio L; Erminio G; Granata C; Holmes K; Gambart M; Buffa P; Castel V; Valteau Couanet D; Garaventa A; Pistorio A; Cecchetto G; Martucciello G; Mattioli G; Sarnacki S
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28440012
[TBL] [Abstract][Full Text] [Related]
5. Unresectable thoracic neuroblastic tumors: Changes in image-defined risk factors after chemotherapy and impact on surgical management.
Delforge X; De Cambourg P; Defachelles AS; Haffreingue A; Rod J; Kassite I; Chabani N; Lauriot-Dit-Prevost A; Gourmel A; Arnaud A; Duchesne C; Thebaud E; Leclair MD
Pediatr Blood Cancer; 2021 Dec; 68(12):e29260. PubMed ID: 34302705
[TBL] [Abstract][Full Text] [Related]
6. Significance of image-defined risk factors for surgical complications in patients with abdominal neuroblastoma.
Günther P; Holland-Cunz S; Schupp CJ; Stockklausner C; Hinz U; Schenk JP
Eur J Pediatr Surg; 2011 Oct; 21(5):314-7. PubMed ID: 21780020
[TBL] [Abstract][Full Text] [Related]
7. Image-defined Risk Factors Correlate with Surgical Radicality and Local Recurrence in Patients with Neuroblastoma.
Pohl A; Erichsen M; Stehr M; Hubertus J; Bergmann F; Kammer B; von Schweinitz D
Klin Padiatr; 2016 Apr; 228(3):118-23. PubMed ID: 26930233
[TBL] [Abstract][Full Text] [Related]
8. Preoperative computed tomography scanning for abdominal neuroblastomas is superior to magnetic resonance imaging for safe surgical planning.
Burnand K; Barone G; McHugh K; Cross K
Pediatr Blood Cancer; 2019 Nov; 66(11):e27955. PubMed ID: 31393056
[TBL] [Abstract][Full Text] [Related]
9. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Canale S; Sarnacki S
Pediatr Blood Cancer; 2015 Feb; 62(2):257-261. PubMed ID: 25284263
[TBL] [Abstract][Full Text] [Related]
10. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?
Yoneda A; Nishikawa M; Uehara S; Oue T; Usui N; Inoue M; Fukuzawa M; Okuyama H
Pediatr Surg Int; 2016 Mar; 32(3):209-14. PubMed ID: 26763000
[TBL] [Abstract][Full Text] [Related]
11. Can Image-Defined Risk Factors Predict Surgical Complications in Localized Neuroblastoma?
Yoneda A; Nishikawa M; Uehara S; Oue T; Usui N; Inoue M; Fukuzawa M; Okuyama H
Eur J Pediatr Surg; 2016 Feb; 26(1):117-22. PubMed ID: 26528852
[TBL] [Abstract][Full Text] [Related]
12. Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age.
Kushner BH; LaQuaglia MP; Bonilla MA; Lindsley K; Rosenfield N; Yeh S; Eddy J; Gerald WL; Heller G; Cheung NK
J Clin Oncol; 1994 Dec; 12(12):2607-13. PubMed ID: 7527454
[TBL] [Abstract][Full Text] [Related]
13. Association of image-defined risk factors, tumor resectability, and prognosis in children with localized neuroblastoma.
Zhang AA; Pan C; Xu M; Wang XX; Ye QD; Gao YJ; Tang JY
World J Pediatr; 2019 Dec; 15(6):572-579. PubMed ID: 31342464
[TBL] [Abstract][Full Text] [Related]
14. Changes in image-defined risk factors with neoadjuvant chemotherapy in pediatric abdominal neuroblastoma.
Wang H; Chen X; Zhu J; Zhang K; Lu J; Zhang L; Ding H; He L
Abdom Radiol (NY); 2022 Oct; 47(10):3520-3530. PubMed ID: 35790567
[TBL] [Abstract][Full Text] [Related]
15. Association of image-defined risk factors with clinical features, histopathology, and outcomes in neuroblastoma.
Temple WC; Vo KT; Matthay KK; Balliu B; Coleman C; Michlitsch J; Phelps A; Behr S; Zapala MA
Cancer Med; 2021 Apr; 10(7):2232-2241. PubMed ID: 33314708
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Bagatell R; Rumcheva P; London WB; Cohn SL; Look AT; Brodeur GM; Frantz C; Joshi V; Thorner P; Rao PV; Castleberry R; Bowman LC
J Clin Oncol; 2005 Dec; 23(34):8819-27. PubMed ID: 16314642
[TBL] [Abstract][Full Text] [Related]
17. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
18. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
[TBL] [Abstract][Full Text] [Related]
19. Minimally invasive surgery for neuroblastic tumours: A SIOPEN multicentre study: Proposal for guidelines.
Gabra HO; Irtan S; Cross K; Lobos P; Froeba-Pohl A; Pio L; Virgone C; Guillén Burrieza G; Gómez Chacón Villalba J; Riccipetitoni G; Guérin F; Nightingale M; Heloury Y; Faraj S; Leclair M; Scalabre A; Mattioli G; Warmann SW; Fuchs J; Basta N; Bjørnland K; Matthyssens LE; Losty PD; Sarnacki S
Eur J Surg Oncol; 2022 Jan; 48(1):283-291. PubMed ID: 34489122
[TBL] [Abstract][Full Text] [Related]
20. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.
Fumino S; Kimura K; Iehara T; Nishimura M; Nakamura S; Souzaki R; Nishie A; Taguchi T; Hosoi H; Tajiri T
J Pediatr Surg; 2015 Dec; 50(12):2102-6. PubMed ID: 26388125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
